Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

The inhibition of the newly discovered cytosolic carbonic anhydrase (CA, EC 4.2.1.1) isozyme XIII of murine origin (mCA XIII) has been investigated with a series of anions, such as the physiological ones (bicarbonate, chloride), or the metal complexing anions (cyanate, cyanide, azide, hydrogen sulfide, etc), nitrate, nitrite, sulfate, sulfamate, sulfamide as well as with phenylboronic and phenylarsonic acids. The best mCA XIII inhibitors were cyanate, thiocyanate, cyanide and sulfamide, with K(I)-s in the range of 0.25microM-0.74 mM, whereas fluoride, iodide, azide, carbonate and hydrogen sulfide were less effective (K(I)-s in the range of 3.0-5.5mM). The least effective inhibitors were sulfate, chloride and bicarbonate (K(I)-s in the range of 138-267 mM). The affinity of mCA XIII for anions is very different from that of the other cytosolic isozymes (hCA I and II) or the mitochondrial isozyme hCA V. This resistance to inhibition by the physiological anions bicarbonate and chloride suggests an evolutionary adaptation of CA XIII to the presence of high concentrations of such anions (e.g., in the reproductive tract of both female and male), and the possible participation of this isozyme (similarly to CA II, CA IV and CA V) in metabolons with proteins involved in the anion exchange and transport, such as the anion exchangers (AE1-3) or the sodium bicarbonate co-transporter (NBC1 and NBC3) proteins, which remain to be identified.

Knowledge Graph

Similar Paper

Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions
Bioorganic & Medicinal Chemistry Letters 2004.0
Carbonic anhydrase inhibitors: Inhibition of the cytosolic human isozyme VII with anions
Bioorganic & Medicinal Chemistry Letters 2006.0
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design
Bioorganic & Medicinal Chemistry Letters 2004.0
Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions
Bioorganic & Medicinal Chemistry Letters 2004.0
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates
Bioorganic & Medicinal Chemistry Letters 2008.0
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions
Bioorganic & Medicinal Chemistry Letters 2004.0
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition
Bioorganic & Medicinal Chemistry Letters 2013.0
Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions
Bioorganic & Medicinal Chemistry Letters 2007.0
Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives
European Journal of Medicinal Chemistry 2011.0
Anion and sulfonamide inhibition studies of an α-carbonic anhydrase from the Antarctic hemoglobinless fish Chionodraco hamatus
Bioorganic & Medicinal Chemistry Letters 2015.0